<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03269890</url>
  </required_header>
  <id_info>
    <org_study_id>MS/17.03.138</org_study_id>
    <nct_id>NCT03269890</nct_id>
  </id_info>
  <brief_title>The Efficacy of Intermediate Cervical Plexus Block Versus Cutaneous and Thyroid Capsular Blocks</brief_title>
  <official_title>The Efficacy of Intermediate Cervical Plexus Block Versus Cutaneous and Thyroid Capsular Blocks in Thyroid Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thyroid gland surgery is one of the most commonly performed operations for either benign or&#xD;
      malignant pathologies Pain related to thyroid surgery is of moderate intensity .which may be&#xD;
      treated with NSAIDs or opioids. However, Opioids have many well-known undesirable effects,&#xD;
      including postoperative nausea and vomiting, which are frequent after this type of procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regional techniques of anesthesia may help to decrease post-operative pain and reduce&#xD;
      systemic analgesic requirement. Classically, the cervical plexus is considered to have two&#xD;
      distributions, the superficial cutaneous and the deep motor nerves.&#xD;
&#xD;
      Anatomically, the thyroid gland has an inner true capsule which is thin and adheres closely&#xD;
      to the thyroidal tissue [Fancy et al., 2010]. External to this is a false capsule formed by&#xD;
      the middle layer of the deep cervical fascia, which splits anterolaterally to ensheathe the&#xD;
      thyroid gland, thus forming the thyroid sheath [Bliss et al., 2000]. In this fashion, the&#xD;
      potential space called the capsule-sheath space is formed. It contains also loose connective&#xD;
      tissue, blood vessels, nerves and parathyroid gland. Anesthetic deposited in this space would&#xD;
      block the surface of thyroid gland and permeate directly into the parenchyma producing&#xD;
      effective local anesthesia for thyroid surgical procedures. It is supposed also to involve&#xD;
      autonomic nerve block of the thyroid gland [Fliers et al., 2010]. Additionally, a&#xD;
      subcutaneous injection along the sternocleidomastoid muscle (SCM) would also enhance&#xD;
      effective local anesthesia for the initial skin incision and further contribute to a more&#xD;
      ideal working environment for the surgeon. Therefore, anesthetic technique termed&#xD;
      ultrasound-guided capsule-sheath space block (CSSB) combined with anterior cervical cutaneous&#xD;
      nerves block (CCNB) for thyroidectomy is done [Wang et al., 2015] .&#xD;
&#xD;
      Our hypothesis is that a combination of simple dual techniques including superficial&#xD;
      cutaneous block to provide sensory blockade, and surgeon mediated capsular block may afford&#xD;
      autonomic thyroid blockade. In comparison, ultrasound guided intermediate cervical plexus&#xD;
      block may provide these blocks but using a machine and deep penetration possibly involving&#xD;
      unwanted blocks for phrenic and recurrent laryngeal nerves. So, if the simple safe technique&#xD;
      can provide the same intra and postoperative anesthetic conditions it will be preferred.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Actual">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total dose of opioid analgesics used</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>The total dose of opioid analgesics required in the post-operative periods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>Postoperative visual analogue score (VAS) (0 no pain -10 worst imaginable pain),</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first analgesic request</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>Time to first request for a rescue analgesic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fentanyl use</measure>
    <time_frame>For 5 hours after start of anaesthesia</time_frame>
    <description>Intraoperative use of fentanyl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rocuronium use</measure>
    <time_frame>For 5 hours after start of anaesthesia</time_frame>
    <description>Intraoperative use of rocuronium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory blockade</measure>
    <time_frame>for 1 hour after surgery</time_frame>
    <description>Assessment of sensory blockade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragmatic dysfunction</measure>
    <time_frame>for 5 hours after performing blockade</time_frame>
    <description>Diaphragmatic dysfunction using ultrasound assessment and possible x ray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation score</measure>
    <time_frame>for 5 hours after performing blockade</time_frame>
    <description>Sedation score using Modified Ramsay scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>for 24 hrs after surgery</time_frame>
    <description>Patient satisfaction regards analgesia using a score of (0-10) with 10 represents the highest satisfaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative headache</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hoarseness of voice</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dysphagia</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory difficulty</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>Peripheral oxygen saturation less than 92%</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Thyroid Surgery</condition>
  <arm_group>
    <arm_group_label>Capsule and cutaneous blocks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7.5 mL of 0.5% bupivacaine + Epinephrine 5 ug/ ml for both blocks per side. once before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US-intermediate cervical plexus block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 mL of 0.5% isobaric bupivacaine + Epinephrine 5 microgram/ ml. per side. once before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Capsule and cutaneous blocks</intervention_name>
    <description>7.5 mL of 0.5% bupivacaine + Epinephrine 5 ug/ ml for both blocks once before surgery per side</description>
    <arm_group_label>Capsule and cutaneous blocks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>US-intermediate cervical plexus block</intervention_name>
    <description>15 mL of 0.5% bupivacaine + Epinephrine 5 ug/ ml once before surgery per side.</description>
    <arm_group_label>US-intermediate cervical plexus block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status grade I and grade II.&#xD;
&#xD;
          -  Euthyroidism after thyroid function tests&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal.&#xD;
&#xD;
          -  Thyroid gland more than 5 cm size.&#xD;
&#xD;
          -  Retrosternal extension.&#xD;
&#xD;
          -  Planned block neck dissection.&#xD;
&#xD;
          -  Neuromuscular diseases&#xD;
&#xD;
          -  Hematological diseases.&#xD;
&#xD;
          -  Bleeding diseases.&#xD;
&#xD;
          -  Coagulation abnormality.&#xD;
&#xD;
          -  Psychiatric diseases.&#xD;
&#xD;
          -  Drug abuse.&#xD;
&#xD;
          -  Local skin infection&#xD;
&#xD;
          -  sepsis at site of the block.&#xD;
&#xD;
          -  Known intolerance to the study drugs.&#xD;
&#xD;
          -  Body Mass Index &gt; 40 Kg/m2.&#xD;
&#xD;
          -  Known diaphragmatic motion abnormalities&#xD;
&#xD;
          -  major respiratory disease.&#xD;
&#xD;
          -  Previous history of cervical surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moneir O El-Hefny, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Anesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oncolgy Center, Mansoura University,</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <zip>53316</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 29, 2017</study_first_submitted>
  <study_first_submitted_qc>August 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>September 19, 2020</last_update_submitted>
  <last_update_submitted_qc>September 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

